Search results
Is CRISPR Therapeutics Stock a Buy?
Motley Fool via Yahoo Finance· 11 hours agoCRISPR Therapeutics (NASDAQ: CRSP) is a star in the gene-editing therapy niche. The company made tremendous progress over the past few years, culminating...
BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
TipRanks via Yahoo Finance· 4 hours agoLast week, Bluebird Bio (NASDAQ:BLUE) shares climbed while CRISPR Therapeutics (NASDAQ:CRSP) stock...
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Zacks via Yahoo Finance· 4 days agoRecently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes...
CRISPR Therapeutics AG [CRSP] Records 200-Day SMA of $59.40 – Knox Daily
Knox Daily· 17 hours agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics AG shares valued at $1,173,232 ...
CRISPR Therapeutics’ (CRSP) Neutral Rating Reiterated at Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoCantor Fitzgerald reissued their neutral rating on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research note issued to investors on Thursday ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 2 days agoCRISPR Therapeutics (NASDAQ: CRSP) closed last week down 8.5% after reporting first-quarter...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 7 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the ...
Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher
Simply Wall St. via Yahoo Finance· 6 days agoCRISPR Therapeutics AG (NASDAQ:CRSP) shareholders will have a reason to smile today, with the...
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
InvestorPlace via Yahoo Finance· 6 days agoThe biotech sector holds some of the most promising and popular stocks on the market. With the...
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
InvestorPlace· 14 hours agoAll on excitement for its injectable and oral treatments for weight loss, both of which are still in...